相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile
Elfriede Dall et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2012)
Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M
Robert Smith et al.
BIOCHIMIE (2012)
Targeting Cell Surface Alpha(v)beta(3) Integrin Increases Therapeutic Efficacies of a Legumain Protease-Activated Auristatin Prodrug
Yuan Liu et al.
MOLECULAR PHARMACEUTICS (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Asparaginyl endopeptidase cleaves TDP-43 in brain
Jeremy H. Herskowitz et al.
PROTEOMICS (2012)
Autophagic activity measured in whole rat hepatocytes as the accumulation of a novel BHMT fragment (p10), generated in amphisomes by the asparaginyl proteinase, legumain
Anders Overbye et al.
AUTOPHAGY (2011)
Asparagine endopeptidase is required for normal kidney physiology and homeostasis
Gail Miller et al.
FASEB JOURNAL (2011)
Nucleoplasmic calcium regulates cell proliferation through legumain
Viviane Andrade et al.
JOURNAL OF HEPATOLOGY (2011)
Nuclear cysteine cathepsin variants in thyroid carcinoma cells
Sofia Tedelind et al.
BIOLOGICAL CHEMISTRY (2010)
Cystatin E/M suppresses legumain activity and invasion of human melanoma
Jon J. Briggs et al.
BMC CANCER (2010)
Blastocystis Legumain Is Localized on the Cell Surface, and Specific Inhibition of Its Activity Implicates a Pro-survival Role for the Enzyme
Binhui Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MEROPS: the peptidase database
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2010)
Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions
Silvia Jordans et al.
BMC BIOCHEMISTRY (2009)
Critical Role for Asparagine Endopeptidase in Endocytic Toll-like Receptor Signaling in Dendritic Cells
Fernando E. Sepulveda et al.
IMMUNITY (2009)
Localization of nuclear cathepsin L and its association with disease progression and poor outcome in colorectal cancer
Shane Sullivan et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The Biology of Cystatin M/E and its Cognate Target Proteases
Patrick L. J. M. Zeeuwen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome
Chi-Bun Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs
Shunichi Kosugi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cysteine cathepsins: Cellular roadmap to different functions
Klaudia Brix et al.
BIOCHIMIE (2008)
Cathepsin L Proteolytically Processes Histone H3 During Mouse Embryonic Stem Cell Differentiation
Elizabeth M. Duncan et al.
CELL (2008)
Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase
Zhixue Liu et al.
MOLECULAR CELL (2008)
DNA accelerates the inhibition of human cathepsin V by serpins
Poh Chee Ong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation
Brigitte Goulet et al.
MOLECULAR CANCER RESEARCH (2007)
Legumain expression as a prognostic factor in breast cancer patients
Jessica Gawenda et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site - A novel clue for the role of cystatin M/E in epidermal cornification
Tsing Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice
R Maehr et al.
JOURNAL OF IMMUNOLOGY (2005)
Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer
RV Murthy et al.
CLINICAL CANCER RESEARCH (2005)
Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s)
S Kamada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor
B Goulet et al.
MOLECULAR CELL (2004)
Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice
K Flatmark et al.
EUROPEAN JOURNAL OF CANCER (2004)
Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice
PLJM Zeeuwen et al.
HUMAN MOLECULAR GENETICS (2004)
Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo
DTN Ni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice
K Shirahama-Noda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer
K Flatmark et al.
JOURNAL OF PATHOLOGY (2003)
Processing and activation of lysosomal proteinases
K Ishidoh et al.
BIOLOGICAL CHEMISTRY (2002)
Legumain from bovine kidney: its purification, molecular cloning, immunohistochemical localization and degradation of annexin II and vitamin D-binding protein
T Yamane et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2002)